Use of bromodomain-containing protein 9 antagonists in combination with vitamin D receptor agonists in diabetes treatment
05-07-2022 дата публикации
Номер:
US0011376264B2
Принадлежит: Salk Institute for Biological Studies
Контакты:
Номер заявки: 12-73-1673
Дата заявки: 08-01-2020
























CPC - классификация
AA6A61A61KA61K3A61K31A61K31/A61K31/4A61K31/42A61K31/427A61K31/43A61K31/436A61K31/4365A61K31/44A61K31/443A61K31/4439A61K31/5A61K31/59A61K31/592A61K31/593A61K4A61K45A61K45/A61K45/0A61K45/06A61K9A61K9/A61K9/0A61K9/00A61K9/001A61K9/0019A61PA61P3A61P3/A61P3/1A61P3/10A61P37A61P37/A61P37/0A61P37/00IPC - классификация
AA6A61A61KA61K3A61K31A61K31/A61K31/4A61K31/42A61K31/427A61K31/43A61K31/436A61K31/4365A61K31/44A61K31/443A61K31/4439A61K31/5A61K31/59A61K31/592A61K4A61K45A61K45/A61K45/0A61K45/06A61K9A61K9/A61K9/0A61K9/00A61PA61P1A61P1/A61P1/1A61P1/16A61P3A61P3/A61P3/1A61P3/10A61P35A61P35/A61P35/0A61P35/00Цитирование НПИ
AU 2008323903 Office Action dated Mar. 6, 2013 (6 pages).Abramovitch et al., “Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats,” Gut, 60:1728-1737, 2011.
Adorini el al., “Inhibition of Type 1 Diabetes Development by Vitamin D Receptor Agonists,” Curr Med Chem.—Anti-Inflammatory & Anti-Allergy Agents 4:645-651, 2005.
Author unknown, “Support plug that skin injection to increase the risk of acute pancreatitis,” Adverse Drug Reactions 11:71, 2009 (with English machine translation).
Beer et al., “A Phase I Trial of Pulse Calcitriol in Patients with Refractory Malignancies,” Cancer 91:2431-2439, 2001.
CA 2703994 Office Action dated Nov. 4, 2015 (3 pages).
CA 2703994 Office Action dated Nov. 6, 2014 (6 pages).
CN 201480035908.4 Office Action dated Jul. 27, 2017 (with English translation) (6 pages).
Cai Hongneng, “Paclitaxel combination chemotherapy film adenocarcinoma,” 3 Yu Cheng Zhangwei by the Affiliated Hospital of Beijing Military Medical Sciences, Beijing 100039, China, 1997 (with English machine translation).
Cao et al., “Leptin Stimulates Tissue Inhibitor of Metalloproteinase-1 in Human Hepatic Stellate Cells,” J. Biol. Chem., vol. 279, pp. 4292-4304, 2004.
Cohen-Lahav et al., “The Anti-Inflammatory Activity of 1,25-Dihydroxyvitamin D3 in Macrophages,” J. Steroid. Biochem. Mol. Biol., vol. 103, pp. 558-562, 2007.
Dai et al., “PPAR gamma is an important transcription factor in 1 alpha, 25-dihydroxyvitaim D3-induced involucrin expression,” J. Derm. Sci, vol. 51, No. 1, pp. 53-60, Apr. 2008.
Demetter et al., “Molecular Changes in Pancreatic Cancer: Implications for Molecular Targeting Therapy,” Acta Gastro-Enterological Belgica 75:210-214, 2012.
Ding et al., “A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response,” Cell, vol. 153, No. 3, pp. 601-613, Apr. 25, 2013.
Dunlop et al., “The human peroxisome proliferator-activated receptor δ gene is a primary target of 1α,25-dihydroxy vitamin D3and it nuclear receptor,” J. Mol. Biol., vol. 349, No. 2, pp. 248-260, Jun. 2005.
EP 08846682.6 Office Action dated Apr. 18, 2013 (6 pages).
EP 08846682.6 Office Action dated Aug. 8, 2017 (5 pages).
EP 08846682.6 Office Action dated Feb. 1, 2016 (5 pages).
EP 08846682.6 Search Report dated Nov. 9, 2010 (12 pages).
EP 14787709.6 Communication Pursuant to Rule 164(1) EPC dated Sep. 13, 2016 with Supplementary Partial European Search Report dated Aug. 19, 2016 (dated Sep. 13, 2016) (9 pages).
EP 14787709.6 Exam Report dated Dec. 5, 2018 (7 pages).
EP 14806812.5 Rule 164(1) EPC Communication dated Nov. 3, 2016 with Supplementary Partial European Search Report dated Oct. 25, 2016 (11 pages).
Fearon, “The Carcinoma-Associated Fibroblast Expressing Fibroblast Activation Protein and Escape from Immune Surveillance,” Cancer Immunol Res. 2:187-193, 2014.
Feig et al., “Targeting CXCL12 from FAP-Expressing Carcinoma-Associated Fibroblasts Synergizes with Anti-PD-L1 Immunotherapy in Pancreatic Cancer,” Proc Natl Acad Sci. USA 110:20212-20217, 2013.
Gao et al., “Pancreatic Stellate Cells Increase the Invasion of Human Pancreatic Cancer Cells through the Stromal Cell-Derived Factor-1/CXCR4 Axis,” Pancreatedology 10:186-193, 2010.
Gascon-Barré et al., “The Normal Liver Harbors the Vitamin D Nuclear Receptor in Nonparenchymal and Biliary Epithelial Cells,” Hepatology, 37:1034-1042, 2003.
Johnson et al., “The Activated Mesangial Cell: A Glomerular ‘Myofibroblast’?,” J. Am. Soc. Nephrol., vol. 2, pp. S190-S197, 1992.
Johnson et al., “The Antitumor Efficacy of Calcitriol: Preclinical Studies,” Anticancer Res. 26:2543-2500, 2006.
Jonas et al., “Measurement of Parenchymal Function and Bile Duct Flow in Primary Sclerosing Cholangitis Using Dynamic99mTc-HIDA SPECT,” J. Gastroenterol. Hepatol. vol. 21, pp. 674-681, 2006.
Klöppel et al., “Fibrosis of the pancreas: the initial tissue damage and the resulting pattern,” Virchows Arch, vol. 445, pp. 1-8, May 2004.
Li et al., “Mannose 6-Phosphate-Modified Bovine Serum Albumin Nanoparticles for Controlled and Targeted Delivery of Sodium Ferulate for Treatment of Heptatic Fibrosis,” J Pharm Pharmacol. 61:1155-1161, 2009.
Ma et al., “1.25D3enhances antitumor activity of gemcitabine and cisplatin in human bladder cancel models,” Cancer, 116:3294-3303, Jul. 1, 2010.
Mahadevan & Hoff, “Tumor-stroma interactions in pancreatic ductual adenocaricinoma,” Mol Cancer Ther. 6:1186-1197, 2007.
Martin et al., J. Med. Chem. (2016) vol. 59, pp. 4462-4475.
McCarroll et al., “Vitamin A inhibits pancreatic stellate cell activation: implications for treatment of pancreatic fibrosis,” Gut 55:79-89, 2006.
Milczarek et al., “Vitamin D Analogs Enhance the Anticancer Activity of 5-Fluorouracil in an in vivo Mouse Colon Cancer Model,” BMC Cancer 13:294 (2013).
Omary et al., “The Pancreatic Stellate Cell: A Star on the Rise in Pancreatic Diseases,” J. Clin. Invest. vol. 117, pp. 50-59, 2007.
PCT/US2014/035235 International Search Report and Written Opinion dated Sep. 17, 2014 (18 pages).
PCT/US2014/041063 International Search Report and Written Opinion dated Sep. 5, 2014 (10 pages).
PCT/US2018/043345 International Search Report and Written Opinion dated Sep. 12, 2018 (11 pages).
Payer et al., “Vitamin D Deficiency as One of the Causes of Bone Changes in Chronic Pancreatitis,” Vnitr Lek. 45:281-283, 1999. (English Abstract Only).
Petta et al., “Low Vitamin D Serum Level Is Related to Severe Fibrosis and Low Responsiveness to Interferon-Based Therapy in Genotype 1 Chronic Hepatitis C,” Hepatology, vol. 51, pp. 1158-1167, 2010.
Remillard et al., “Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands,” Angew Chem Int Ed Engl. 56:5738-5743, 2017.
Samer et al., “Rat Primary and Immortalized Human Hepatocytes Express an Inducible and Functional Vitamin D Receptor,” Abstract, Hepatology & Luminal Research Workshop & Clinical Update on Non-Invasive Markers of Liver Injury and Early Diagnosis of Liver Disease, 1-3, Yarra Valley, Victoria, Australia, May 2009.
Sato et al., “Resolution of Liver Cirrhosis Using Vitamin A-Coupled Liposomes to Deliver siRNA Against a Collagen-Specific Chaperone,” Nat Biotechnol. 26:431-442, 2008.
Sheng-Nan et al., Chin. Phys. B (2014) vol. 23(3), pp. 037503-1 to 037503-19.
Shi et al., Nano Lett. (2010) vol. 10(9), pp. 3223-3230.
Suda et al., “Pancreatic fibrosis in patients with chronic alcohol abuse: correlation with alcoholic pancreatitis,” Am J Gastroenterol, 89:2060-2062, Nov. 1994.
Tan et al., “Paricalcitol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy,” J. Am. Soc. Nephrol, vol. 17, pp. 3382-3393, 2006.
Tan et al., “Therapeutic Role and Potential Mechanisms of Active Vitamin D in Renal Interstitial Fibrosis,” J. Steroid. Biochem. Mol. Biol., 103:491-496, 2007.
Theodoulou et al., “Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition,” J Med Chem. 59:1425-1439, 2016.
Wehr et al., “Analysis of the Human Pancreatic Stellate Cell Secreted Proteome,” Pancreas 40:557-566, 2011.
Whitcomb, “Genetic aspects of pancreatitis,” Annual Review of Medicine, vol. 61, pp. 413-424, Palo Alto, 2010.
Wurm and Frey, “Linear-Dendritic Block Copolymers: The State of the Art and Exciting Perspectives,” Polymer Sci. 36:1-52, 2011.
Zehnder et al., “Expression of 25-Hydroxyvitamin D3-1alpha-hydroxylase in the Human Kidney,” J. Am. Soc. Nephrol., vol. 10, pp. 2465-2473, 1999.
Zhang et al., “Interactions of Nanomaterials and Biological Systems: Implications to Personalized Nanomedicine,” Adv Drug Deliv. 64:1363-1384, 2012.
Zhang, “Advances mechanism and antifibrotic treatment of chronic pancreatitis film gland fibrosis,” Chin J Pancreatol. 1:56-58, 2001 (with English machine translation).
Zollner et al., “Role of Nuclear Receptors in the Adaptive Response to Bile Acids and Cholestasis: Pathogenetic and Therapeutic Considerations,” Mol. Pharm., vol. 3, pp. 231-251, 2006.